Deficits in Endogenous Adenosine Formation by Ecto-5′-Nucleotidase/CD73 Impair Neuromuscular Transmission and Immune Competence in Experimental Autoimmune Myasthenia Gravis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Oliveira, Laura ^a   Correia, Alexandra ^a,b   Cristina Costa, Ana ^a   Guerra Gomes, Sónia ^a   Ferreirinha, Fátima ^a   Magalhães Cardoso, Maria Teresa ^a   Vilanova, Manuel ^a,b   Correia De Sá, Paulo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; CD4 ANTIGEN; ECTO 5' NUCLEOTIDASE; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS; FEMALE; IMMUNOCOMPETENCE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOLECULAR PATHOLOGY; NERVE ENDING; NEUROMUSCULAR TRANSMISSION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; WISTAR RAT; ANIMAL; BLOOD; DEFICIENCY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MUSCLE CONTRACTION; MYASTHENIA GRAVIS; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALIA; RATTUS;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; FEMALE; MUSCLE CONTRACTION; MYASTHENIA GRAVIS; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION; T-LYMPHOCYTES, REGULATORY;

EID: 84932102762     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/460610     Document Type: Article

References (42)

1. J. M. Lindstrom, "Acetylcholine receptors and myasthenia, " Muscle & Nerve, vol. 23, no. 4, pp. 453-477, 2000.
2. B. M. Conti-Fine, M. Milani, and H. J. Kaminski, "Myasthenia gravis: past, present, and future, " Journal of Clinical Investigation, vol. 116, no. 11, pp. 2843-2854, 2006.
3. N. P. Hirsch, "Neuromuscular junction in health and disease, " British Journal of Anaesthesia, vol. 99, no. 1, pp. 132-138, 2007.
4. P. Correia-de-Sá, A. M. Sebastião, and J. A. Ribeiro, "Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat, " British Journal of Pharmacology, vol. 103, no. 2, pp. 1614-1620, 1991.
5. B. Csóka, L. Himer, Z. Selmeczy et al., "Adenosine A2 receptor activation inhibits T helper 1 and T helper 2 cell development and effector function, " The FASEB Journal, vol. 22, no. 10, pp. 3491-3499, 2008.
6. L. Oliveira, M. A. Timóteo, and P. Correia-de-Sá, "Tetanic depression is overcome by tonic adenosine A2A receptor facilitation of L-type Ca2+ influx into rat motor nerve terminals, " Journal of Physiology, vol. 560, no. 1, pp. 157-168, 2004.
7. J. B. Noronha-Matos, T. Morais, D. Trigo et al., "Tetanic failure due to decreased endogenous adenosine A2 tonus operating neuronal Cav1 (L-type) influx in Myasthenia gravis, " Journal of Neurochemistry, vol. 117, no. 5, pp. 797-811, 2011.
8. N. Li, L. Mu, J. Wang et al., "Activation of the adenosine A2A receptor attenuates experimental autoimmunemyasthenia gravis severity, " European Journal of Immunology, vol. 42, no. 5, pp. 1140-1151, 2012.
9. S. Huang, S. Apasov, M. Koshiba, and M. Sitkovsky, "Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion, " Blood, vol. 90, no. 4, pp. 1600-1610, 1997.
10. P. E. Zarek, C.-T. Huang, E. R. Lutz et al., "A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells, " Blood, vol. 111, no. 1, pp. 251-259, 2008.
11. R. A. Cunha, P. Correia-de-Sá, A. M. Sebastião, and J. A. Ribeiro, "Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides, " British Journal of Pharmacology, vol. 119, no. 2, pp. 253-260, 1996.
12. P. Correia-de-Sá, M. A. Timóteo, and J. A. Ribeiro, "Presynaptic A1 inhibitory/A(2A) facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm, " Journal of Neurophysiology, vol. 76, no. 6, pp. 3910-3919, 1996.
13. M. T. Magalhães-Cardoso, M. F. Pereira, L. Oliveira, J. A. Ribeiro, R. A. Cunha, and P. Correia-de-Sá, "Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at ratmotor nerve endings, " Journal of Physiology, vol. 549, no. 2, pp. 399-408, 2003.
14. G. Borsellino, M. Kleinewietfeld, D. DiMitri et al., "Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression, " Blood, vol. 110, no. 4, pp. 1225-1232, 2007.
15. F. Baggi, A. Annoni, F. Ubiali et al., "Breakdown of tolerance to a self-peptide of acetylcholine receptor -subunit induces experimentalmyasthenia gravis in rats, " Journal of Immunology, vol. 172, no. 4, pp. 2697-2703, 2004.
16. G. Giusti, "Adenosine deaminase, " in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 1092-1099, Academic Press, New York, NY, USA, 1974.
17. E. Van Lunteren, M. Moyer, andH. J. Kaminski, "Adverse effects of myasthenia gravis on rat phrenic diaphragm contractile performance, " Journal of Applied Physiology, vol. 97, no. 3, pp. 895-901, 2004.
18. A. R. Pinheiro, D. Paramos-de-Carvalho, M. Certal et al., "Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation, " The Journal of Biological Chemistry, vol. 288, no. 38, pp. 27571-27583, 2013.
19. M. Fausther, J. Lecka, E. Soliman et al., "Coexpression of ecto-5-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 302, no. 4, pp. G447-G459, 2012.
20. H. Link and B. G. Xiao, "Rat models as tool to develop new immunotherapies, " Immunological Reviews, vol. 184, pp. 117-128, 2001.
21. S. Chiba, M. Saitoh, M. Kashiwagi, N. Kobayashi, and H. Matsumoto, "Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis, " Internal Medicine, vol. 34, no. 2, pp. 81-84, 1995.
22. Y. Zhang, H.-B. Wang, L.-J. Chi, and W.-Z. Wang, "The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis, " Immunology Letters, vol. 122, no. 1, pp. 52-57, 2009.
23. A. Shore, H.-M. Dosch, and E. W. Gelfand, "Role of adenosine deaminase in the early stages of precursor T cell maturation, " Clinical and Experimental Immunology, vol. 44, no. 1, pp. 152-155, 1981.
24. S. Gertel-Lapter, K. Mizrachi, S. Berrih-Aknin, S. Fuchs, and M. C. Souroujon, "Impairment of regulatory T cells in myasthenia gravis: Studies in an experimentalmodel, " Autoimmunity Reviews, vol. 12, no. 9, pp. 894-903, 2013.
25. L. Mu, B. Sun, Q. Kong et al., "Disequilibrium of T helper type 1, 2 and 17 cells and regulatory T cells during the development of experimental autoimmune myasthenia gravis, " Immunology, vol. 128, no. 1, pp. e826-e836, 2009.
26. A. Balandina, S. Lécart, P. Dartevelle, A. Saoudi, and S. Berrih-Aknin, "Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis, " Blood, vol. 105, no. 2, pp. 735-741, 2005.
27. A. V. Sauer, I. Brigida, N. Carriglio et al., "Alterations in the adenosinemetabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADAdeficient SCID, " Blood, vol. 119, no. 6, pp. 1428-1439, 2012.
28. V. Macdermot, "The changes in the motor end-plate in myasthenia gravis, " Brain, vol. 83, no. 1, pp. 24-36, 1960.
29. V. C. Juel and J. M. Massey, "Myasthenia gravis, " Orphanet Journal of Rare Diseases, vol. 2, no. 1, article 44, 2007.
30. E. Tüzün and P. Christadoss, "Unraveling myasthenia gravis immunopathogenesis using animal models, " Drug Discovery Today: Disease Models, vol. 3, no. 1, pp. 15-20, 2006.
31. M. Mandapathil, B. Hilldorfer, M. J. Szczepanski et al., "Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T Cells, " The Journal of Biological Chemistry, vol. 285, no. 10, pp. 7176-7186, 2010.
32. S. Deaglio, K. M. Dwyer, W. Gao et al., "Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, " Journal of Experimental Medicine, vol. 204, no. 6, pp. 1257-1265, 2007.
33. V. Nessi, S. Nava, C. Ruocco et al., "Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis, " Journal of Immunology, vol. 185, no. 9, pp. 5656-5667, 2010.
34. C. Vieira, F. Ferreirinha, I. Silva, M. Duarte-Araújo, and P. Correia-de-Sá, "Localization and function of adenosine receptor subtypes at the longitudinal muscle-myenteric plexus of the rat ileum, " Neurochemistry International, vol. 59, no. 7, pp. 1043-1055, 2011.
35. P. Correia-de-Sá and J. A. Ribeiro, "Adenosine uptake and deamination regulate tonic A2 receptor facilitation of evoked 3H acetylcholine release from the rat motor nerve terminals acetylcholine release from the rat motor nerve terminals, " Neuroscience, vol. 73, no. 1, pp. 85-92, 1996.
36. J. J. Plomp, G. T. van Kempen, and P. C. Molenaar, "Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in bungarotoxin-treated rats, " Journal of Physiology, vol. 458, pp. 487-499, 1992.
37. M. Faria, L. Oliveira, M. A. Timóteo, M. G. Lobo, andP. Correiade-Sá, "Blockade of neuronal facilitatory nicotinic receptors containing 32 subunits contribute to tetanic fade in the rat isolated diaphragm, " Synapse, vol. 49, no. 2, pp. 77-88, 2003.
38. S.-F. Ko, C.-C. Huang, M.-J. Hsieh et al., "31P MR spectroscopic assessment of muscle in patients with myasthenia gravis before and after thymectomy: initial experience, " Radiology, vol. 247, no. 1, pp. 162-169, 2008.
39. D. O. Smith, "Sources of adenosine released during neuromuscular transmission in the rat, " Journal of Physiology, vol. 432, pp. 343-354, 1991.
40. S. Buvinic, G. Almarza, M. Bustamante et al., "ATP released by electrical stimuli elicits calcium transients and gene expression in skeletal muscle, " Journal of Biological Chemistry, vol. 284, no. 50, pp. 34490-34505, 2009.
41. A. El-Tayeb, J. Iqbal, A. Behrenswerth et al., "Nucleoside-5-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5-nucleotidase, " Journal ofMedicinal Chemistry, vol. 52, no. 23, pp. 7669-7677, 2009.
42. U. Flögel, S. Burghoff, P. L. E. M. Van Lent et al., "Selective activation of adenosine A2 receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis, " Science Translational Medicine, vol. 4, no. 146, Article ID 146ra108, 2012.